Steroid Archives - Rheumatology Advisor

Data from a population-based case control study found that systemic glucocorticoid use was associated with increased risk of S. aureus bacteremia (CA-SAB), with a clear dose-response relationship.

Rheumatoid Arthritis

Quantification of Incident Diabetes Risk With Glucocorticoid Tx in RA

By

Lauren Grygotis, Editor

May 23, 2016

Recent glucocorticoid use contributed most to the current risk of diabetes, while doses taken more than 6 months previously did not.

Rheumatoid Arthritis

EULAR Consensus on Long-Term Use of Glucocorticoids

By

Dee Rapposelli

March 21, 2016

A multidisciplinary EULAR task force reviewed the literature on dose-dependent risks related to glucocorticoid therapy in the management of chronic inflammatory rheumatic disease.

Rheumatoid Arthritis

Certain Doses of Methylprednisolone for Injection Currently in Shortage

By

Diana Ernst, RPh

March 13, 2016

The FDA is reporting a shortage in certain presentations of Solu-Medrol Powder for Injection (Pfizer) and the generic Methylprednisolone sodium succinate for injection (Fresenius Kabi).

Vasculitis

Can Tocilizumab Be Steroid-Sparing While Maintaining Remission in GCA?

By

Corinna Sison, MD

March 10, 2016

This is the first randomized placebo-controlled trial to demonstrate the induction and remission efficacy of IL-6 inhibition with tocilizumab in patients with giant cell arteritis (GCA).

Osteoarthritis

Timing of Intraarticular Hip Injection Changes Risk of Periprosthetic Joint Infection

By

Corinna Sison, MD

March 3, 2016

This study found that patients receiving intraarticular (IA) hip injections within 12 weeks of elective total hip arthroplasty (THA) are at increased risk of periprosthetic joint infection (PJI).